New Therapeutic Agents in Thrombosis and Thrombolysis

New Therapeutic Agents in Thrombosis and Thrombolysis

by Arthur A Sasahara

Join Readfeed freeFind clubs reading this
Rate this book:

Browse books you can read free on Readfeed

No club is reading this yet — be the first to start one

Start a club free
About
Presents new chapters discussing the latest research on low-molecular-weight heparins, as well as agents such as pentasaccharide, TFP1, soluble thrombomodulin, and alfimeprase.Completely revised and expanded throughout, New Therapeutic Agents in Thrombosis and Thrombolysis details strategies totarget conventional and recently characterized pathways of hemostasisminimize the prothrombotic function of activated plateletsassess the biochemical and pharmacological effects of antithrombotic agentsand discussesthe use of animal models for determination of antithrombotic drug efficacyantithrombotic therapy as a key component of cardiovascular disease managementthe management of thromboembolic events in children and pregnant womenSupplemented with more than 2000 contemporary references, New Therapeutic Agents in Thrombosis and Thrombolysis is an authoritative source for cardiologists, internists, primary care physicians, vascular medicine specialists, cardiovascular and vascular surgeons, hematologists, pulmonologists, critical care physicians, pharmacologists, pharmaceutical researchers, and fellows, residents, and graduate and medical school students in these disciplines.

Discuss New Therapeutic Agents in Thrombosis and Thrombolysis with other readers

Join or start a book club for New Therapeutic Agents in Thrombosis and Thrombolysis on Readfeed. Live chat, shared reading progress, and AI discussion questions — free to get started.

Sign up freeBrowse book clubs

Frequently asked questions

How do I join a book club for New Therapeutic Agents in Thrombosis and Thrombolysis?

Sign up free on Readfeed, then browse public clubs or start your own club with New Therapeutic Agents in Thrombosis and Thrombolysis as the current read. Invite friends with a share link and discuss together with live chat and AI discussion questions.

Can I discuss New Therapeutic Agents in Thrombosis and Thrombolysis with other readers online?

Yes. Readfeed book clubs let you chat live, share progress, and join discussions about New Therapeutic Agents in Thrombosis and Thrombolysis with readers worldwide — whether your club is virtual, in-person, or hybrid.

Is Readfeed free?

Yes. Creating an account and joining book clubs is free. Sign up to find readers who love the same books and start discussing today.